Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

VITT

The Lasting Immunological Footprint of VITT - JTH
Jun 24, 2026, 09:18 | Science
The Lasting Immunological Footprint of VITT - JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Adam…
What Happens When Molecular Science and Clinical Insight Move Together? - McMaster University Department of Medicine
Jun 10, 2026, 05:29 | Voices
What Happens When Molecular Science and Clinical Insight Move Together? - McMaster University Department of Medicine
McMaster University Department of Medicine shared on LinkedIn: ''What happens when molecular science and clinical…
Tushar Pandey: When Low Platelets Are Not ITP
Apr 27, 2026, 14:31 | Voices
Tushar Pandey: When Low Platelets Are Not ITP
Tushar Pandey, Director and Head of Raghav Institute of Hematology, Hemato-Oncology and BMT at Raghav…
Jack Hadfield: Understanding the Immune and Genetic Basis of VITT Post-COVID Vaccines
Apr 22, 2026, 11:17 | Science
Jack Hadfield: Understanding the Immune and Genetic Basis of VITT Post-COVID Vaccines
Jack Hadfield, Co-founder and Research Lead at Amatica Health, shared on Linkedin about a recent article…
Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
Apr 7, 2026, 19:17 | Science
Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
Anand Padmanabhan, Professor and Clinician-Investigator at Mayo Clinic, shared a post on LinkedIn about a recent article…
Anand Padmanabhan: A New Concise Nutshell Review of MGTS as an Emerging Thrombophilia
Apr 6, 2026, 16:21 | Science
Anand Padmanabhan: A New Concise Nutshell Review of MGTS as an Emerging Thrombophilia
Anand Padmanabhan, Professor and Clinician-Investigator at Mayo Clinic, shared a post on LinkedIn about a…
Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
Mar 20, 2026, 17:47 | Voices
Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
Julie Rayes, Associate Professor at University of Birmingham, shared a post on LinkedIn about a…
Wolfgang Miesbach: From Heparin to Vaccines - The Expanding Biology of Anti-PF4 Immunothrombosis
Mar 12, 2026, 20:02 | Insight
Wolfgang Miesbach: From Heparin to Vaccines - The Expanding Biology of Anti-PF4 Immunothrombosis
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn: ''Anti-PF4…
Abdul Mannan: Explaining the Molecular Mechanism Behind VITT
Mar 9, 2026, 16:06 | Voices
Abdul Mannan: Explaining the Molecular Mechanism Behind VITT
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn about…
Lucy Rutten: An Important Mechanistic Insight Into Future Vaccine Safety
Feb 21, 2026, 12:23 | Science
Lucy Rutten: An Important Mechanistic Insight Into Future Vaccine Safety
Lucy Rutten, Senior Scientist at Leiden University, shared on LinkedIn about a recent article she and…
Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
Feb 19, 2026, 14:54 | Insight
Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
Michela Mazzon, Virologist and Founder of Virology Research Services Ltd, shared on LinkedIn: ''This week…
Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
Feb 17, 2026, 15:38 | Science
Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn, about…
Goran Mitulović: Proteomics and Mass Spectroscopy Identified The Cause of VITT
Feb 12, 2026, 11:19 | Science
Goran Mitulović: Proteomics and Mass Spectroscopy Identified The Cause of VITT
Goran Mitulović, Senior Application Development Scientist (Field based) at Bruker Daltonics, shared on LinkedIn about a…
PF4 Antibody Persistence and Long-term Pathogenicity in VITT
Nov 29, 2025, 16:38 | Science
PF4 Antibody Persistence and Long-term Pathogenicity in VITT
Anand Padmanabhan, Professor and Consultant at Mayo Clinic, shared on LinkedIn: ''Congrats to Adam Kanack,…
Richard Buka: Catching up with Dr. Sue Pavord on BSH + Some Extra Nuggets
Nov 9, 2025, 11:36 | Voices
Richard Buka: Catching up with Dr. Sue Pavord on BSH + Some Extra Nuggets
Richard Buka, Academic Clinical Lecturer in Haematology at the University of Birmingham, posted on LinkedIn:…
Nicolas Gendron: From HIT to VITT
Oct 28, 2025, 07:00 | Science
Nicolas Gendron: From HIT to VITT
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared a post on LinkedIn: ”From HIT…
Ishac Nazy: Proud Moment For Our Team!
Oct 22, 2025, 09:32 | Science
Ishac Nazy: Proud Moment For Our Team!
Ishac Nazy, Professor at McMaster University, shared on LinkedIn: ''Proud moment for our team! Our…
Pip Nicolson: Understanding VITT From COVID-19 Vaccines
Aug 13, 2025, 06:13 | Science
Pip Nicolson: Understanding VITT From COVID-19 Vaccines
Pip Nicolson, Associate Clinical Professor in Cardiovascular Medicine (Haematology) at University of Birmingham, shared an…
All: 18 Posts: 1 - 100
NewsFeed